Home › Funds › Englebert Financial Advisers, LLC › PRAX

Englebert Financial Advisers, LLC position in PRAX

PRAXIS PRECISION MEDICINES I · Health Care

Englebert Financial Advisers, LLC reported holding 1,306 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$437K, representing 0.44% of its reported portfolio and ranking #43 among its reported holdings. Englebert Financial Advisers, LLC has disclosed PRAX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.31K sh
Reported value held$437.24K
Portfolio Weight0.44%
First reportedQ1 2026
Last changeNew

How Englebert Financial Advisers, LLC's PRAX position evolved

Englebert Financial Advisers, LLC first disclosed a stake in PRAX in Q1 2026 at 789 shares (US$254K). The position peaked in Q2 2026 at 1,306 shares, worth US$437K. Across 2 filings, Englebert Financial Advisers, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,306 shares valued at US$437K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 789 $254.21K New
Q2 2026 1.31K $437.24K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRAX and 13F data

PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 74 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRAX

All PRAX fund holders →